NASDAQ: BGLC
Bionexus Gene Lab Corp Stock Ownership - Who owns Bionexus Gene Lab?

Insider buying vs selling

Have Bionexus Gene Lab Corp insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BGLC insiders and whales buy or sell their stock.

BGLC Shareholders

What type of owners hold Bionexus Gene Lab Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Tai Tan Liong695.79%12,500,460$36.44MInsider
Wei Li Leong267.04%4,797,709$13.99MInsider
Citadel Advisors LLC5.50%98,768$287.91kInstitution
Two Sigma Investments LP1.98%35,532$103.58kInstitution
Geode Capital Management LLC1.32%23,681$69.03kInstitution
Ubs Group Ag0.00%4$11.66Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

BGLC vs Specialty Chemical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BGLC0.91%99.09%
SNES0.23%99.77%
CNEY40.48%0.00%
SDST11.30%88.41%Net SellingNet Selling
FSI9.13%48.27%

Bionexus Gene Lab Stock Ownership FAQ

Who owns Bionexus Gene Lab?

Bionexus Gene Lab (NASDAQ: BGLC) is owned by 8.79% institutional shareholders, 962.83% Bionexus Gene Lab insiders, and 0.00% retail investors. Tai Tan Liong is the largest individual Bionexus Gene Lab shareholder, owning 12.50M shares representing 695.79% of the company. Tai Tan Liong's Bionexus Gene Lab shares are currently valued at $34.53M.

If you're new to stock investing, here's how to buy Bionexus Gene Lab stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.